Skip to main content
Download PDF

Update: Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular mass

BMC Nephrology volume 16, Article number: 120 (2015) Cite this article

Abstract

After the publication of our paper Dunlop et al. “Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular mass”, we became aware of further data correlating left ventricular (LV) mass index at baseline and their correpsonding mass at 12 months, using cardiac margnetic resonanace imaging (MRI) in patients on hemodialysis. The original published sample size for the SoLID trial of 118 was a conservative estimate, calculated using analysis of covariance and a within person Pearson’s correlation for LV mass index of 0.75. New data communicated to the SoLID trial group has resulted in re-calcuation of the sample size, based upon a within person Pearson’s correlation of 0.8 but otherwise unchanged assumptions. As a result, the SoLID trial will now recruit 96 participants.

Update

After the publication of our paper Dunlop et al. “Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular mass” [1], we became aware of further data correlating left ventricular (LV) mass index at baseline and their correpsonding mass at 12 months, using cardiac margnetic resonanace imaging (MRI) in patients on hemodialysis.

The original published sample size for the SoLID trial of 118 was a conservative estimate, calculated using repeated-measures analysis of covariance (ANCOVA) and a within person Pearson’s correlation for LV mass index of 0.75. The assumption of a correlation of 0.75 was based on private communication from the Jardine group (private communication P Mark 8/2/2011) [2–4]: in a cohort of 59 patients of their patients with repeated measures of LVMI at least 6 months apart (using cardiac MRI), correlation was 0.87 (p < 0.001) with normally distributed data. Modelling these data, and allowing for 25 % for drop outs, it was determined that 59 participants would be enrolled in each arm (power 0.8, alpha 0.05).

New data communicated to the SoLID trial group has resulted in us re-calculating sample size for the SoLID trial (private communication C McIntyre and A Odudu 30/4/2014) [5]: in a cohort of 44 patients of their patients with repeated measures of LV mass index 12 months apart (using cardiac MRI), correlation was 0.81 (p < 0.001). In 21 of these patients, there was an intervention that might have modestly affected their LV mass index; however, restricting analysis to the 23 paired values in the control group provides a similar correlation of 0.83.

Based on the data above, the sample size has been recalculated using a within person correlation of 0.8, but otherwise unchanged assumptions. It is was determined that 48 participants will be enrolled in each arm. The change in sample size has been approved by the National (New Zealand) Multi-region Ethics Committee (IRB00004663) of the New Zealand Ministry of Health (IORG0000895), and the primary funding body for this study the Health Research Council of New Zealand.

References

  1. Dunlop JL, Vandal AC, de Zoysa JR, Gabriel RS, Haloob IA, Hood CJ, et al. Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular mass. BMC Nephrol. 2013;14:149.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Mark PB, Patel RK, Jardine AG. Are we overestimating left ventricular abnormalities in end-stage renal disease? Nephrol Dial Transplant. 2007;22(7):1815–9.

    Article  PubMed  Google Scholar 

  3. Patel RK, Jardine AG, Mark PB, Cunningham AF, Steedman T, Powell JR, et al. Association of left atrial volume with mortality among ESRD patients with left ventricular hypertrophy referred for kidney transplantation. Am J Kidney Dis. 2010;55(6):1088–96.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Patel RK, Oliver S, Mark PB, Powell JR, McQuarrie EP, Traynor JP, et al. Determinants of left ventricular mass and hypertrophy in hemodialysis patients assessed by cardiac magnetic resonance imaging. Clin J Am Soc Nephrol. 2009;4(9):1477–83.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Odudu A, Eldehni MT, Fakis A, McIntyre CW. Rationale and design of a multi-centre randomised controlled trial of individualised cooled dialysate to prevent left ventricular systolic dysfunction in haemodialysis patients. BMC Nephrol. 2012;13:45.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Auckland Clinical School, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 93311, Otahuhu, Auckland, 1640, New Zealand

    Joanna Leigh Dunlop & Mark Roger Marshall

  2. Department of Renal Medicine, Middlemore Hospital, Counties Manukau District Health Board, Private Bag 93311, Otahuhu, Auckland, 1640, New Zealand

    Joanna Leigh Dunlop, Christopher John Hood & Mark Roger Marshall

  3. Faculty of Health and Environmental Sciences, Auckland University of Technology, North Shore Campus, Private Bag 92006, Auckland, 1142, New Zealand

    Alain Charles Vandal

  4. Ko Awatea, Middlemore Hospital, Counties Manukau District Health Board, Private Bag 93311, Otahuhu, Auckland, 1640, New Zealand

    Alain Charles Vandal

  5. Renal Service, North Shore Hospital, Waitemata District Health Board, Private Bag 93503, Takapuna, Auckland, 0740, New Zealand

    Janak Rashme de Zoysa

  6. Department of Cardiology, Middlemore Hospital, Counties Manukau District Health Board, Private Bag 93311, Otahuhu, Auckland, 1640, New Zealand

    Ruvin Sampath Gabriel

  7. Bathurst Health Service, New South Wales, Australia

    Imad Adbi Haloob

  8. Department of Nephrology, Wellington Hospital, Capital & Coast District Health Board, Private Bag 7902, Wellington South, New Zealand

    Philip James Matheson

  9. Department of Nephrology, Christchurch Hospital, Canterbury District Health Board, Private Bag 4710, Christchurch, New Zealand

    David Owen Ross McGregor

  10. Department of Renal Medicine, Waikato Hospital, Waikato District Health Board, Private Bag 3200, Hamilton, 3240, New Zealand

    Kannaiyan Samuel Rabindranath

  11. Department of Renal Medicine, Auckland City Hospital, Auckland District Health Board, Private Bag 92024, Auckland, Auckland, 0740, New Zealand

    David John Semple

  12. Medical Affairs - Renal (Asia Pacific), Baxter Healthcare, P.O. Box 14062, Panmure, Auckland, 1741, New Zealand

    Mark Roger Marshall

Authors
  1. Joanna Leigh Dunlop
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alain Charles Vandal
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Janak Rashme de Zoysa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ruvin Sampath Gabriel
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Imad Adbi Haloob
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Christopher John Hood
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Philip James Matheson
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. David Owen Ross McGregor
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Kannaiyan Samuel Rabindranath
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. David John Semple
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Mark Roger Marshall
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mark Roger Marshall.

Additional information

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

JLD participated in the trial design, and drafted the manuscript. ACV participated in the trial design, developed the statistical plan, and helped to draft the manuscript. MRM conceived and developed the trial, and participated in the statistical plan and helped to draft the manuscript. RSG, IAH, and DORM participated in design and development of the trial, and helped to draft the manuscript. JRdZ and PJM participated in the trial design and coordination, and helped to draft the manuscript. CJH, KSR, and DJS participated in the trial coordination and implementation, and helped to draft the manuscript. All authors read and approved the final manuscript.

Acknowledgments

The SoLID trial is funded through grants from the Health Research Council of New Zealand, the Maurice and Phyllis Paykel Trust and the Royal Australasian College of Physicians (RACP) Research Foundation. JLD is a current recipient of an RACP Jacquot Research Entry Scholarship, and MRM is a current recipient of an RACP Jacquot Research Establishment Fellowships. The SoLID trial research team would like to acknowledge the kindness of the Jacquot Family in supporting nephrological research in Australasia, and the kindness of Mr and Mrs Kwun Kwok and their son Mr Siu Hang Kok for supporting nephrological research at Counties Manukau District Health Board. The SoLID trial research team would also like to acknowledge the Australasian Kidney Trial Network (http://www.aktn.org.au), for providing advice and assistance on the design of the trial.

The online version of the original article can be found under doi:10.1186/1471-2369-14-149.

Rights and permissions

Open Access  This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.

The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.

The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dunlop, J.L., Vandal, A.C., de Zoysa, J.R. et al. Update: Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular mass. BMC Nephrol 16, 120 (2015). https://doi.org/10.1186/s12882-015-0080-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12882-015-0080-y

Keywords

  • Public Health
  • Internal Medicine
  • Repeated Measure
  • Research Council
  • Randomise Control Trial

BMC Nephrology

ISSN: 1471-2369

Contact us